N/A
N=600
Skin Health Online for Melanoma: Better Risk Assessment
Melanoma (Skin)
Bottom Line
View on ClinicalTrials.gov: NCT03130569 ↗Enrolled (actual)
600
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Reach of Personalized Genomic Testing for Melanoma. — 0; 204; 0; 295 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Web-based Module Group (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of New Mexico
- Primary completion
- Aug 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Reach of Personalized Genomic Testing for Melanoma. |
0; 204; 0; 295 | — |
Summary
This study will have two phases, with an added usability test after Phase I and before Phase 2. Phase 1: Cognitive Interviews of materials in Spanish. Phase 2: Personalized Genomic Testing for Skin Cancer (PGT-SC). The overarching goal of this study is to learn more about how to maximize the availability, comprehension and appropriate uptake of personalized genomics among different populations in New Mexico. Primary Care patients will be recruited in their primary health clinic to complete surveys about their understanding and beliefs of skin cancer and behaviors that might help prevent skin cancer. 6 out of every 7 patients will then be asked to go to a website to learn more about skin cancer risk. Once participants have completed the education modules on this site, participants will be given the option to request and complete a skin cancer genetic testing kit. All participants will be contacted again after three months to complete a follow-up set of surveys about skin cancer.
Eligibility Criteria
Inclusion Criteria
- Registered at a University of New Mexico primary care clinic for ≥6 months
- Assigned to a primary care provider
- Fluent in either English or Spanish
Exclusion Criteria
- Unable to consent
- <18 years old
- Prisoner
Data sourced from ClinicalTrials.gov (NCT03130569). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.